Report Detail
Global Respiratory Distress Syndrome Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4716524 |
- 29 June, 2026 |
- Global |
- 89 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global Respiratory Distress Syndrome market size was valued at US$ 454 million in 2025 and is forecast to a readjusted size of US$ 652 million by 2032 with a CAGR of 5.4% during review period.
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
This report is a detailed and comprehensive analysis for global Respiratory Distress Syndrome market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Respiratory Distress Syndrome market size and forecasts, in consumption value ($ Million), 2021-2032
Global Respiratory Distress Syndrome market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Respiratory Distress Syndrome market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Respiratory Distress Syndrome market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Respiratory Distress Syndrome
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Respiratory Distress Syndrome market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Respiratory Distress Syndrome market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Poractant Alfa
Beractant
Calfactant
Others
Market segment by Application
Very Preterm Infants
Moderate to Late Preterm Infants
Others
Market segment by players, this report covers
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Respiratory Distress Syndrome product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Respiratory Distress Syndrome, with revenue, gross margin, and global market share of Respiratory Distress Syndrome from 2021 to 2026.
Chapter 3, the Respiratory Distress Syndrome competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Respiratory Distress Syndrome market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Respiratory Distress Syndrome.
Chapter 13, to describe Respiratory Distress Syndrome research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Respiratory Distress Syndrome by Type
- 1.3.1 Overview: Global Respiratory Distress Syndrome Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Respiratory Distress Syndrome Consumption Value Market Share by Type in 2025
- 1.3.3 Poractant Alfa
- 1.3.4 Beractant
- 1.3.5 Calfactant
- 1.3.6 Others
- 1.4 Global Respiratory Distress Syndrome Market by Application
- 1.4.1 Overview: Global Respiratory Distress Syndrome Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Very Preterm Infants
- 1.4.3 Moderate to Late Preterm Infants
- 1.4.4 Others
- 1.5 Global Respiratory Distress Syndrome Market Size & Forecast
- 1.6 Global Respiratory Distress Syndrome Market Size and Forecast by Region
- 1.6.1 Global Respiratory Distress Syndrome Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Respiratory Distress Syndrome Market Size by Region, (2021-2032)
- 1.6.3 North America Respiratory Distress Syndrome Market Size and Prospect (2021-2032)
- 1.6.4 Europe Respiratory Distress Syndrome Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Respiratory Distress Syndrome Market Size and Prospect (2021-2032)
- 1.6.6 South America Respiratory Distress Syndrome Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Respiratory Distress Syndrome Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Chiesi Farmaceutici
- 2.1.1 Chiesi Farmaceutici Details
- 2.1.2 Chiesi Farmaceutici Major Business
- 2.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Product and Solutions
- 2.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Chiesi Farmaceutici Recent Developments and Future Plans
- 2.2 CR-Double Crane
- 2.2.1 CR-Double Crane Details
- 2.2.2 CR-Double Crane Major Business
- 2.2.3 CR-Double Crane Respiratory Distress Syndrome Product and Solutions
- 2.2.4 CR-Double Crane Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 CR-Double Crane Recent Developments and Future Plans
- 2.3 ONY Biotech
- 2.3.1 ONY Biotech Details
- 2.3.2 ONY Biotech Major Business
- 2.3.3 ONY Biotech Respiratory Distress Syndrome Product and Solutions
- 2.3.4 ONY Biotech Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 ONY Biotech Recent Developments and Future Plans
- 2.4 AbbVie
- 2.4.1 AbbVie Details
- 2.4.2 AbbVie Major Business
- 2.4.3 AbbVie Respiratory Distress Syndrome Product and Solutions
- 2.4.4 AbbVie Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 AbbVie Recent Developments and Future Plans
- 2.5 Yuhan Corporation
- 2.5.1 Yuhan Corporation Details
- 2.5.2 Yuhan Corporation Major Business
- 2.5.3 Yuhan Corporation Respiratory Distress Syndrome Product and Solutions
- 2.5.4 Yuhan Corporation Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Yuhan Corporation Recent Developments and Future Plans
- 2.6 JW Pharmaceuticals
- 2.6.1 JW Pharmaceuticals Details
- 2.6.2 JW Pharmaceuticals Major Business
- 2.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Product and Solutions
- 2.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 JW Pharmaceuticals Recent Developments and Future Plans
- 2.7 Noargen
- 2.7.1 Noargen Details
- 2.7.2 Noargen Major Business
- 2.7.3 Noargen Respiratory Distress Syndrome Product and Solutions
- 2.7.4 Noargen Respiratory Distress Syndrome Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Noargen Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Respiratory Distress Syndrome Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Respiratory Distress Syndrome by Company Revenue
- 3.2.2 Top 3 Respiratory Distress Syndrome Players Market Share in 2025
- 3.2.3 Top 6 Respiratory Distress Syndrome Players Market Share in 2025
- 3.3 Respiratory Distress Syndrome Market: Overall Company Footprint Analysis
- 3.3.1 Respiratory Distress Syndrome Market: Region Footprint
- 3.3.2 Respiratory Distress Syndrome Market: Company Product Type Footprint
- 3.3.3 Respiratory Distress Syndrome Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Respiratory Distress Syndrome Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Respiratory Distress Syndrome Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Respiratory Distress Syndrome Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Respiratory Distress Syndrome Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Respiratory Distress Syndrome Consumption Value by Type (2021-2032)
- 6.2 North America Respiratory Distress Syndrome Market Size by Application (2021-2032)
- 6.3 North America Respiratory Distress Syndrome Market Size by Country
- 6.3.1 North America Respiratory Distress Syndrome Consumption Value by Country (2021-2032)
- 6.3.2 United States Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 6.3.3 Canada Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Respiratory Distress Syndrome Consumption Value by Type (2021-2032)
- 7.2 Europe Respiratory Distress Syndrome Consumption Value by Application (2021-2032)
- 7.3 Europe Respiratory Distress Syndrome Market Size by Country
- 7.3.1 Europe Respiratory Distress Syndrome Consumption Value by Country (2021-2032)
- 7.3.2 Germany Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 7.3.3 France Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 7.3.5 Russia Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 7.3.6 Italy Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Respiratory Distress Syndrome Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Respiratory Distress Syndrome Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Respiratory Distress Syndrome Market Size by Region
- 8.3.1 Asia-Pacific Respiratory Distress Syndrome Consumption Value by Region (2021-2032)
- 8.3.2 China Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 8.3.3 Japan Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 8.3.5 India Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 8.3.7 Australia Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Respiratory Distress Syndrome Consumption Value by Type (2021-2032)
- 9.2 South America Respiratory Distress Syndrome Consumption Value by Application (2021-2032)
- 9.3 South America Respiratory Distress Syndrome Market Size by Country
- 9.3.1 South America Respiratory Distress Syndrome Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Respiratory Distress Syndrome Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Respiratory Distress Syndrome Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Respiratory Distress Syndrome Market Size by Country
- 10.3.1 Middle East & Africa Respiratory Distress Syndrome Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
- 10.3.4 UAE Respiratory Distress Syndrome Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Respiratory Distress Syndrome Market Drivers
- 11.2 Respiratory Distress Syndrome Market Restraints
- 11.3 Respiratory Distress Syndrome Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Respiratory Distress Syndrome Industry Chain
- 12.2 Respiratory Distress Syndrome Upstream Analysis
- 12.3 Respiratory Distress Syndrome Midstream Analysis
- 12.4 Respiratory Distress Syndrome Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Respiratory Distress Syndrome. Industry analysis & Market Report on Respiratory Distress Syndrome is a syndicated market report, published as Global Respiratory Distress Syndrome Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Respiratory Distress Syndrome market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
